Brainstorm Cell Therapeutics Inc Cash Flow Quality Index
Brainstorm Cell Therapeutics Inc cash flow quality index. Brainstorm Cell Therapeutics Inc (BCLI) has a Cash Flow Quality Index of -10.63x as of December 2017. Operating cash flow of $-2.94 Million is below net income of $276.00K, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Brainstorm Cell Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Brainstorm Cell Therapeutics Inc Cash Flow Quality Index by Year (None–None)
Brainstorm Cell Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Brainstorm Cell Therapeutics Inc. For the full cash flow conversion analysis, see BCLI operating cash flow.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|